Continue to site >
Trending ETFs

Name

As of 03/27/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$10.14

$3.54 B

0.00%

$0.00

1.76%

Vitals

YTD Return

9.6%

1 yr return

23.6%

3 Yr Avg Return

-7.1%

5 Yr Avg Return

7.0%

Net Assets

$3.54 B

Holdings in Top 10

20.9%

52 WEEK LOW AND HIGH

$10.0
N/A
N/A

Expenses

OPERATING FEES

Expense Ratio 1.76%

SALES FEES

Front Load N/A

Deferred Load 1.00%

TRADING FEES

Turnover N/A

Redemption Fee N/A


Min Investment

Standard (Taxable)

$1,000

IRA

N/A


Fund Classification

Fund Type

Open End Mutual Fund


Name

As of 03/27/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$10.14

$3.54 B

0.00%

$0.00

1.76%

OSGCX - Profile

Distributions

  • YTD Total Return 9.6%
  • 3 Yr Annualized Total Return -7.1%
  • 5 Yr Annualized Total Return 7.0%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -1.44%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annual

Fund Details

  • Legal Name
    JPMorgan Small Cap Growth Fund
  • Fund Family Name
    JPMorgan
  • Inception Date
    Dec 15, 1999
  • Shares Outstanding
    5257529
  • Share Class
    C
  • Currency
    USD
  • Domiciled Country
    US
  • Manager
    Eytan Shapiro

OSGCX - Performance

Return Ranking - Trailing

Period OSGCX Return Category Return Low Category Return High Rank in Category (%)
YTD 9.6% -2.7% 19.7% 16.96%
1 Yr 23.6% -0.7% 53.5% 26.67%
3 Yr -7.1%* -21.1% 62.1% 86.20%
5 Yr 7.0%* -3.0% 46.3% 71.18%
10 Yr 7.8%* 1.5% 24.5% 62.63%

* Annualized

Return Ranking - Calendar

Period OSGCX Return Category Return Low Category Return High Rank in Category (%)
2023 13.3% -20.5% 54.6% 60.14%
2022 -33.3% -82.1% 32.2% 67.20%
2021 -26.9% -90.6% 300.1% 93.20%
2020 42.0% -63.0% 127.9% 21.30%
2019 24.8% -7.7% 42.9% 37.60%

Total Return Ranking - Trailing

Period OSGCX Return Category Return Low Category Return High Rank in Category (%)
YTD 9.6% -2.7% 19.7% 16.96%
1 Yr 23.6% -0.7% 53.5% 26.67%
3 Yr -7.1%* -21.1% 62.1% 86.20%
5 Yr 7.0%* -3.0% 46.3% 71.18%
10 Yr 7.8%* 1.5% 24.5% 62.63%

* Annualized

Total Return Ranking - Calendar

Period OSGCX Return Category Return Low Category Return High Rank in Category (%)
2023 13.3% -19.0% 136.8% 72.38%
2022 -32.8% -59.9% 44.3% 78.19%
2021 -6.4% -22.7% 411.9% 95.89%
2020 58.3% 1.5% 150.8% 16.30%
2019 36.5% 5.5% 55.3% 17.18%

NAV & Total Return History


OSGCX - Holdings

Concentration Analysis

OSGCX Category Low Category High OSGCX % Rank
Net Assets 3.54 B 183 K 28.5 B 11.23%
Number of Holdings 132 7 1188 23.83%
Net Assets in Top 10 796 M 57.4 K 2.83 B 11.57%
Weighting of Top 10 20.94% 7.1% 100.1% 60.03%

Top 10 Holdings

  1. JPMorgan Securities Lending Money Market Fund, Class Agency SL Shares 6.39%
  2. Super Micro Computer, Inc. 2.07%
  3. Simpson Manufacturing Co., Inc. 1.85%
  4. Applied Industrial Technologies, Inc. 1.83%
  5. Evolent Health, Inc., Class A 1.64%
  6. AAON, Inc. 1.54%
  7. Rambus, Inc. 1.42%
  8. Casella Waste Systems, Inc., Class A 1.41%
  9. Amicus Therapeutics, Inc. 1.40%
  10. ITT, Inc. 1.39%

Asset Allocation

Weighting Return Low Return High OSGCX % Rank
Stocks
98.58% 77.88% 108.99% 33.68%
Cash
7.85% 0.00% 27.66% 8.46%
Preferred Stocks
0.00% 0.00% 4.08% 39.55%
Other
0.00% -0.22% 5.89% 52.68%
Convertible Bonds
0.00% 0.00% 1.57% 33.85%
Bonds
0.00% 0.00% 3.22% 31.78%

Stock Sector Breakdown

Weighting Return Low Return High OSGCX % Rank
Healthcare
25.68% 0.00% 47.90% 25.56%
Technology
25.46% 2.91% 75.51% 48.53%
Industrials
18.32% 0.00% 36.64% 34.89%
Consumer Cyclical
14.84% 0.00% 24.04% 24.70%
Consumer Defense
6.05% 0.00% 13.56% 16.75%
Financial Services
4.02% 0.00% 42.95% 80.31%
Energy
2.46% 0.00% 55.49% 51.64%
Real Estate
2.25% 0.00% 15.31% 45.77%
Communication Services
0.63% 0.00% 15.31% 75.65%
Utilities
0.25% 0.00% 5.57% 29.19%
Basic Materials
0.03% 0.00% 9.24% 82.04%

Stock Geographic Breakdown

Weighting Return Low Return High OSGCX % Rank
US
98.58% 30.27% 102.09% 30.22%
Non US
0.00% 0.00% 61.74% 48.53%

OSGCX - Expenses

Operational Fees

OSGCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.76% 0.05% 23.20% 19.20%
Management Fee 0.65% 0.05% 1.62% 17.13%
12b-1 Fee 0.75% 0.00% 1.00% 80.19%
Administrative Fee 0.08% 0.01% 0.40% 39.60%

Sales Fees

OSGCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load 1.00% 1.00% 5.00% 35.48%

Trading Fees

OSGCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

OSGCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover N/A 3.00% 439.00% 43.21%

OSGCX - Distributions

Dividend Yield Analysis

OSGCX Category Low Category High OSGCX % Rank
Dividend Yield 0.00% 0.00% 7.17% 44.04%

Dividend Distribution Analysis

OSGCX Category Low Category High Category Mod
Dividend Distribution Frequency Annual Annually SemiAnnual Annual

Net Income Ratio Analysis

OSGCX Category Low Category High OSGCX % Rank
Net Income Ratio -1.44% -2.47% 1.10% 89.84%

Capital Gain Distribution Analysis

OSGCX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Monthly Annually

Distributions History

View More +

OSGCX - Fund Manager Analysis

Managers

Eytan Shapiro


Start Date

Tenure

Tenure Rank

Sep 01, 2004

17.76

17.8%

Eytan Shapiro, managing director, is the CIO of the Growth &Small Cap U.S. Equity Team. Mr. Shapiro has worked as a portfolio manager for JPMIM or its affiliates (or their predecessors) since 1989 and has been employed by the firm since 1985. Eytan holds a B.Sc. in economics from City University, London, an M.Phil. in economics from Oxford University, and is Series 66 licensed. He is a member of both the New York Society of Security Analysts and The CFA Institute, and a CFA charterholder. He began his investment career in 1982.

Felise Agranoff


Start Date

Tenure

Tenure Rank

Nov 01, 2016

5.58

5.6%

Felise L. Agranoff, managing director, is a portfolio manager and research analyst within the U.S. Equity Group. An employee since 2004, Felise is a co-portfolio manager of the Mid Cap Growth, Growth Advantage and Small Cap Growth Strategies. Additionally, she has research responsibility for the small and mid cap industrial sector as well as mid cap financials and business services. Prior to joining the growth team as a research analyst in 2006, Felise previously worked on the J.P. Morgan U.S. Equity Large Cap fundamental research team. Felise obtained a B.S. in Finance and Accounting from the McIntire School of Commerce at the University of Virginia. She is a member of the CFA Institute and a CFA charterholder.

Matthew Cohen


Start Date

Tenure

Tenure Rank

Nov 01, 2016

5.58

5.6%

Matthew G. Cohen, M.D., managing director, is a research analyst in the U.S. Equity Group. An employee since 2005, Dr. Cohen has been portfolio manager since 2015 and a research analyst in the firm’s U.S. Equity Group since 2005. Before joining the firm, Matthew was a senior healthcare analyst at Medici Healthcare and a senior analyst covering medical products at Narragansett Asset Management, a New York-based healthcare hedge fund. Prior to that, Dr. Cohen was a resident surgeon in the Department of General Surgery at the North Shore University Hospital NYU School of Medicine. Matthew holds an M.B.A. from New York University Stern School of Business and an M.D. from McGill University in Montreal.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.08 30.44 9.04 5.25